Distinguishing Tension-Type Headache from Migraine
Tension-type headache presents as bilateral, pressing/tightening pain of mild-to-moderate intensity that is not aggravated by routine activity and lacks both nausea/vomiting and the combination of photophobia plus phonophobia, whereas migraine is characterized by unilateral, pulsating, moderate-to-severe pain aggravated by activity with nausea/vomiting or both photophobia and phonophobia. 1, 2
Clinical Features for Differentiation
Tension-Type Headache Characteristics
- Pain quality and location: Bilateral, pressing or tightening (non-pulsatile) character with mild-to-moderate severity 1, 2
- Activity relationship: Not worsened by routine physical activity such as walking or climbing stairs 1
- Associated symptoms: May have anorexia but typically lacks nausea/vomiting; does not have both photophobia and phonophobia together 1, 2
- Duration: Highly variable, ranging from 30 minutes to 7 days per episode 2
- Behavioral response: Patients predominantly report scalp massage as a relief measure 3
Migraine Characteristics
- Pain quality and location: Unilateral (though can be bilateral), pulsating or throbbing quality with moderate-to-severe intensity 2, 4
- Activity relationship: Aggravated by routine physical activity 2
- Associated symptoms: Nausea/vomiting AND/OR both photophobia and phonophobia present together 2, 4
- Duration: 4-72 hours in adults (2-72 hours in children under 18 years) 2
- Diagnostic threshold: Requires at least 5 lifetime attacks meeting these criteria 2
- Behavioral response: Patients perform significantly more relief maneuvers (mean 6.2 vs 3 for tension-type), including pressing the painful site, applying cold stimuli, attempting to sleep, isolating themselves, and becoming immobile 3
Key Discriminating Features
- The presence of photophobia together with nausea strongly supports migraine and helps differentiate it from tension-type headache 2
- Migraine patients typically seek isolation and immobility during attacks, while tension-type headache patients continue activities 3
- Approximately one-third of migraine patients experience aura (visual, sensory, or speech disturbances lasting 5-60 minutes) preceding or accompanying headache 4, 2
Common Diagnostic Pitfalls
- Overlap exists: Many migraine attacks include tension-like symptoms such as neck pain, and some tension-type headaches may have mild photophobia or phonophobia (but not both together) 5
- Misdiagnosis consequences: Rigid adherence to diagnostic criteria may result in migraine being misdiagnosed as tension-type headache, preventing patients from receiving appropriate migraine-specific treatment 5, 6
- When in doubt, favor migraine: It is reasonable to err on the side of migraine diagnosis when choosing between primary headaches, as migraine is significantly underdiagnosed and undertreated 6
- Chronic forms complicate diagnosis: Chronic tension-type headache (≥15 days/month) can have disability levels comparable to migraine 2
- Medication overuse: Headache on ≥15 days/month with regular overuse of non-opioid analgesics ≥15 days/month or other acute medications ≥10 days/month for ≥3 months indicates medication-overuse headache, which can mimic either condition 2
First-Line Acute Treatment
Tension-Type Headache
- NSAIDs: Ibuprofen 400 mg is first-line acute treatment 4
- Acetaminophen: 1000 mg is an alternative first-line option 4
- Avoid opioids and barbiturates: These carry dependency risk and can lead to medication-overuse headache 4
Migraine
- Mild-to-moderate attacks: NSAIDs or acetaminophen 2
- Moderate-to-severe attacks or NSAID failure: Triptans are first-line 4
- Newer options: CGRP receptor antagonists (gepants) such as ubrogepant or rimegepant are recommended as acute treatment options 4
- Combination therapy: Aspirin-acetaminophen-caffeine combination is effective 4
- Antiemetics: Add for nausea/vomiting 2
- Avoid opioids: Opioids are not recommended due to dependency risk, rebound headaches, and loss of efficacy 4
Preventive Treatment
Tension-Type Headache (Chronic Form)
- Amitriptyline: First-line preventive agent for chronic tension-type headache (≥15 days/month) 4, 2, 7
- Physical therapy: Combination of thermal methods, trigger point massage, and mobilization techniques delivered by a physical therapist 4
- Aerobic exercise: 2-3 times per week for 30-60 minutes 4
Migraine Prevention
First-line options:
- Beta-blockers: Propranolol, metoprolol, atenolol, or bisoprolol (particularly useful with comorbid hypertension) 4, 8
- Angiotensin-receptor blockers: Candesartan 4
- ACE inhibitors: Lisinopril 4
- Antiepileptics: Topiramate 50-100 mg daily (especially beneficial in obese patients) 4, 8
- Valproate (contraindicated in women of childbearing potential) 4
CGRP monoclonal antibodies: Eptinezumab, erenumab, fremanezumab, galcanezumab are options for migraine prevention 4
Newer oral options: Atogepant (oral CGRP antagonist) 4
Botulinum toxin: OnabotulinumtoxinA 155-195 units every 12 weeks is recommended for chronic migraine (≥15 headache days/month with ≥8 meeting migraine criteria) but NOT for episodic migraine or tension-type headache 4, 8
Gabapentin is NOT recommended for episodic migraine prevention 4
Non-Pharmacological Approaches (Both Conditions)
- Physical therapy: Thermal methods, trigger point massage, mobilization and manipulation techniques are beneficial for both migraine and tension-type headache 4
- Aerobic exercise: 2-3 times per week for 30-60 minutes 4
- Progressive strength training: Upper-body exercises, supervised, typically 3 times per week for 30 minutes 4
Treatment Assessment
- Oral preventives: Assess efficacy after 2-3 months at therapeutic dose 8, 2
- CGRP antibodies: Assess after 3-6 months 8
- Botulinum toxin: Assess after 6-9 months 8
- Consider pausing treatment after 6-12 months of successful control to determine if preventive therapy can be stopped 8, 2
- Headache diary: Document frequency, duration, character, triggers, accompanying symptoms, and medication use to facilitate monitoring 2